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1. Introduction  
Food allergy is defined as an abnormal immunological reaction to food proteins, which 
causes an adverse clinical reaction. Today 4–6% of children and 1–3% of adults are affected 
with food allergy in Europe (Mills et al., 2007), while in the USA 6– 8% of children and 4% of 
adults are affected (Gupta et al., 2008). The incidence of food allergy has been increasing 
over the years, and to date, no effective treatment of food allergies is available. Therapies 
involving drugs (antihistamines, decongestants, or steroids) only combat the symptoms of 
an allergic reaction and do not prevent allergenic reactions due to future exposures to the 
allergen. Specific immunotherapy (SIT) is the only prophylactic desensitizing therapy for 
allergy (Bousquet et al., 1998; Durham et al., 1999). However, for food allergies 
immunotherapy safety-profile is extremely poor because allergic reactions are associated 
with a significant risk of anaphylactic side-effects (Nelson et al., 1997; Skripak et al., 2008), 
even with fatal outcome. Therefore, allergen modification resulting in almost complete 
reduction of IgE-binding, while retaining its immunogenicity, could improve formulations 
for immunotherapy of food allergies.  
The best way to prevent unintended exposure to a food allergen is the strict avoidance of 
foodstuffs containing allergens. Such avoidance may not always be possible, and in certain 
instances impossible. Furthermore, complete elimination of foodstuffs causing allergy also 
has negative impact on healthy diet as about 90 % of allergens are present in food of high 
nutrition value (milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, and soybeans) 
(Thompson et al., 2006). Therefore production of hypoallergenic food become increasingly 
indispensable part of food industry with growing demand for methods aimed to reduce 
allergenic potential of food products. There is increasing number of publications describing 
successful attempts to reduce allergenicity of food allergens. A number of studies of food 
processing on allergen reactivity are largely focused on thermal treatments. Although 
thermal treatments can be used on many products to alter food allergen reactivity, thermal 
processing has also been known to modify organoleptic properties, including flavor, color, 
and nutrient content (Holdsworth, 1985). Therefore, novel non-thermal food processing 
techniques are being explored in order to create hypoallergenic products (Shriver & Yang, 
2011). Variable success of methods for allergenicity reduction, due to limited knowledge of 
allergen and epitope structures and the factors governing their stability, imposes need for an 
empirical approach (Soler-Rivas & Wichers, 2001). Chemical or enzymatic modification of 
allergen molecule may alter its structure or physically obstruct binding of IgE antibodies to 
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conformational or linear epitopes. The objective of this review is to thoroughly explore 
chemical and enzymatic processing techniques utilized to modify food allergens, 
highlighting the efficacy of these methods in their ability to alter food allergen reactivity. As 
there are comprehensive reviews on food allergen treatment with digestive enzymes and the 
effects of fermentation on food reactivity, this review is focused on chemical and enzymatic 
modification of food allergen in the narrow sense.  
2. Methods for assessing allergenicity of food products  
The efficacy of chemical and enzymatic methods used to alter food allergen reactivity must 
be verified by analyzing the treated allergen’s (or treated allergenic food) ability to trigger 
an immune response. As the reactivity of an allergen is often described by its ability to bind 
IgE antibodies, reduced IgE activity may indicate a modification or removal of food 
allergen(s). A variety of rapid assay methods are in use as analytical tools in research of 
molecular structure, integrity and biological activity of food allergens and their epitopes. 
Allergen reactivity can be determined by in vitro, ex vivo and in vivo testing. In vitro tests are 
often inexpensive, quick and without a threat to human or animal subjects. On the other 
hand in vivo assays provide a more accurate representation of the research. Ex vivo tests are 
advantageous because they are measuring allergenic response on effector cell level, using 
human subject blood without exposing them to risk. Animal models may also be used, 
though these models are not always analogous to the human. However, animal models may 
be a useful tool for predicting sensitizing potential of proteins introduced into diet by 
genetic manipulation or modified allergens which may carry higher allergenic risk. 
In vivo tests. In vivo detection includes skin prick tests (SPT) and oral food challenges 
(OFC). SPT is simple and inexpensive, but the wheal sizes can vary by allergen and subject 
(Sampson, 1999), subjective results can differ between evaluators (Poulsen, 2001) and 
patients with atopic dermatitis may develop false-positive wheals (Fleischer et al., 2010). 
OFC is considered the ‘‘gold standard’’ in diagnosing food allergy as it can provide more 
accurate information regarding food allergy. However, these tests are complex, expensive 
and time consuming. As subject may experience severe adverse reactions patients who are 
susceptible to anaphylaxis should not be included in this type of study (Fleischer et al., 
2010). However, final proof of improved safety of potentially less allergenic foods must be 
provided through human test studies, via double-blind placebo-controlled food challenge 
(DBPCFC)-tests.  
Animal models. Rodent animal models are the most often exploited animal models of food 
allergy. Though the dosage of the allergen, route of exposure and duration of the build-in 
phase of allergy may differ depending on the allergen used and animal strain, many food 
allergy models have been described in the literature providing generation of IgE in the 
serum upon immunization and/or anaphylaxis reaction upon challenge with allergen. 
Animal models are useful in elucidation of mechanisms involved in reduction of 
allerenicity, especially on B cell and T cell level (Hattori et al., 2000; Kobayashi et al., 2001; 
Kobayashi et al., 2003).  
Ex vivo tests. Ex vivo tests include histamine release or up regulation of surface molecules 
CD63 or CD203c on basophile granulocytes, known as the basophile activation test, BAT. By 
measuring specific IgE we only measure one interaction, between IgE and an allergen, 
whilst an allergic response requires two simultaneous interactions of allergen with IgE on 
the same effector cell. This is simulated in the ex vivo tests based on basophile granulocytes.  
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In vitro tests. In vitro studies for determining allergen reactivity include the measurement of 
serum IgE using radio-allergosorbent tests (RAST), enzyme-allergosorbent tests (EAST), 
enzyme linked immunosorbent assay (ELISA), ImmunoCAP assays (Phadia, Uppsala, 
Sweden); and immunobloting. By RAST, EAST and ELISA (competitive inhibition and 
indirect) multiple samples can be tested at once. However, due to differences with solid 
phase and sample preparation among analysts standardization is the main problem. 
Furthermore, IgG antibodies can compete with IgE antibodies for similar epitopes. Although 
expensive, an ImmunoCAP tests have increased sensitivity compared to RAST, EAST and 
ELISA with minimized nonspecific binding by non-IgE binding antibodies. Immunoblotting 
includes Western blot and dot blot allergen analysis. In Western blotting proteins are most 
often tested in their linear conformation so that conformational epitopes may not be 
represented and new IgE binding epitopes, in native conformation hidden within the 
protein, may be uncovered. Immunobloting is frequently used since protein bands can be 
individually analyzed to determine the changes in a specific allergen. In dot blot 
conformational epitopes may be preserved due to non-denaturing conditions, but in the case 
of protein mixture immunogenicity of the entire sample is analyzed.  
Digestibility assays for food protein allergenicity assessment. The observation that many 
food allergens exhibit proteolytic stability led to allergy assessment strategy that use of 
digestion stability as a criterion for protein allergenicity assessment (Becker, 1997; Besler er 
al., 2001; Taylor & Lehrer, 1996). Although the relationship between the stability of proteins 
in simulated gastric fluid (SGF) and allergenicity has been inconsistent among studies, many 
recent reports proved increased incidence of food allergies in relation to impaired gastric 
digestion in human and animal studies. (Untersmayr & Jensen-Jarolim, 2008). Thomas et al. 
(Thomas et al., 2008) demonstrated that common protocol for evaluating the in vitro 
digestibility of proteins is reproducible and yields consistent results when performed using 
the same proteins at different laboratories. However, digestibility assays of pure proteins 
may not be always relevant in assessing allergenicity potential as they do not account for the 
effects of food matrices (Ofori-Anti et al., 2008). Therefore, in vitro gastrointestinal digestion 
protocols should be preferably combined with immunological assays in order to elucidate 
the role of large digestion-resistant fragments and the influence of the food matrix (Moreno, 
2007). For a comprehensive review on digestibility of food allergens refer to Cirkovic 
Velickovic et al. (Cirkovic Velickovic et al., 2009). Anyway, comparison of unmodified and 
modified food allergen in digestibility studies can give valuable information about allergic 
potential of modified food protein and efficiency of modifying method used. As enzymatic 
and chemical methods change allergen structure digestibility of modified allergen can be 
increased or decreased thus directly influencing allergen availability to gut immune system.  
3. Chemical modifications  
The aim of chemical modifications of proteins used for nutritional purposes, in addition to 
reduction of allergenic properties, is obtaining of proteins with required techno-functional 
properties (solubility, emulsification, foaming, gelling, etc.) and preserved nutritional value. 
Chemical modifications of food proteins can lead to a change in the charge and 
hydrophobicity of proteins, which in turn can diminish or eliminate allergenicity of food 
allergens. However, regardless the application of non-toxic reagents, chemical modifications 
are not so often applied in the food industry regarding complex procedures of removing 
remaining chemical agents. 
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3.1 Covalent modifications  
Acylation. Acylation of allergens by treatment with anhydrides, such as acetic or succinic, 
blocks positively charged amino groups on the protein molecule and the remaining free 
carboxyl groups of aspartic and glutamic acid residues make the net charge of the modified 
protein more negative. Szymkiewicz & Jędrychowski (Szymkiewicz & Jedrychowski, 2009) 
modified pea proteins with acetic or succinic anhydride. Immunoreactivity of albumins and 
legumin, as estimated by ELISA with rabbit polyclonal antibodies, was reduced by 91-99% 
and 78-97% after succinylation and acetylation, respectively, while immunoreactivity of 
vicilin fraction was reduced down to 12% and 17%, respectively. In their other study 
(Szymkiewicz & Jędrychowski, 2008) the authors combined enzymatic hydrolysis by 
Alcalase with chemical modification by acylation of pea proteins. The enzyme hydrolysis of 
acylation-modified pea proteins caused significant reduction in the immunoreactivity of pea 
proteins, especially vicilin, whose epitopes were the most resistant to the modifications, 
both chemical (Szymkiewicz & Jedrychowski, 2009) and enzymatic one (Szymkiewicz & 
Jędrychowski, 2005), applied separately. The application of Alcalase lowered the 
immunoreactivity of vicilin to 2-2.5%, while immunoreactivity of legumin and albumin 
decreased by nearly 100%. Thus, combining various methods of protein modification is 
more efficient and can be a promising approach for preparing products with reduced 
allergenicity. However, in ELISA tests with individual sera of patients allergic to 
leguminous seeds, IgE binging of pea proteins were reduced only by 40-75%, indicating that 
considerable decrease in the antigenicity of proteins not always guarantees their lower 
allergenicity and also shows differences in individual patients. 
Carbamoylation. Mistrello et al. (Mistrello et al., 1996) chemically modified ovalbumin by 
reaction with potassium cyanate (KCNO), which transforms the ε-amino group of the lysine 
of proteinaceous allergens into ureido groups. KCNO-modified (carbamylated) allergens 
have low allergenic potency, as demonstrated in vitro (RAST inhibition) and in vivo (passive 
cutaneous anaphylaxis). When used to immunize rabbits, carbamylated allergens still 
induce IgG antibodies able to cross-react with native allergens (immunoblotting 
experiments). Although potentially useful for immunotherapy formulations preparation this 
method is not suitable for hypoallergic food preparation. 
Nitration. In study of Untersmayr et al. (Untersmayr et al., 2010) BALB/c mice were 
immunized intragastrically by feeding untreated ovalbumin (OA) and nitrated ovalbumin 
(nOA) with or without acid-suppression. While oral immunizations of nOA under anti-acid 
treatment did not result in IgG and IgE formation, intraperitoneal immunization induced 
high levels of OA specific IgE, which were significantly increased in the group that received 
nOA by injection. Furthermore, nOA triggered significantly enhanced mediator release of 
effector cells of sensitized allergic animals. In gastric digestion experiments nOA was 
degraded within few minutes, whereas OA remained stable up to 120 min. Additionally, 
one tyrosine residue being very efficiently nitrated is part of an ovalbumin epitope 
recognized exclusively after oral sensitization. These data indicated that despite the 
enhanced triggering capacity in existing allergy, nitration of OVA may be associated with a 
reduced de novo sensitizing capability via the oral route due to enhanced protein 
digestibility and/or changes in antibody epitopes. Although the authors considered effects 
of endogenously nitrated allergen, these results imply that nitration of food allergen as 
method have no potential for reducing its allergenic potential. 
Conjugation with synthetic copolymer. Conjugates of ovalbumin (OA) and the copolymer 
of N-vinyl pyrrolidone and maleic anhydride (VMA) modified with epsilon-aminocaproic 
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acid (Acp) were prepared by Babakhin et al. (Babakhin et al., 1995). Of all conjugates 
injected intraperitoneally into mice only the conjugate containing 20%OA (OA-Acp-VMA) 
did induce anti-OA IgG antibodies without significant quantities of anti-OA IgE. In passive 
cutaneous anaphylaxis, RAST inhibition and leukocyte histamine release, OA-Acp-VMA 
have shown significant reduction of allergenicity and stimulated activation of the OA-
specific T-cell comparable to that of unconjugated OA. During experimental allergen-
specific hyposensitization with OA-Acp-VMA, suppression of anti-OA IgE response and 
elevation of anti-OA IgG responses were noted. By using the carrier Acp-VMA to reduce 
allergenicity there is selective blockage of B-cell epitopes of allergen without affecting T-cell 
epitopes, thereby preserving immunogenicity, which enable creation of preparations for 
allergen-specific immunotherapy. 
Polymerization by glutaraldehyde. By treatment with glutaraldehyde aldehyde groups of 
glutaraldehyde react with the amino groups of protein resulting in cross-linked allergen 
proteins with altered immunological characteristics (Patterson et al., 1979). Recently the 
ability of glutaraldehyde-treated allergens to stimulate T-cells has been disputed (Wurtzen 
et al., 2007). XiYang et al. (Yang et al., 1993) demonstrated that whereas in vivo 
administration of ovalbumin (OA) induces cytokine synthesis that is neither Thl nor Th2 
dominated, administration of glutaraldehyde polymerized, high relative molecular weight 
OA (OA-POL) leads to 20-fold increase in the ratio of interferon Ǆ (IFN-Ǆ)/IL-4 and IFN-
Ǆ/IL-10 synthesis observed after short-term, antigen-mediated restimulation directly ex vivo. 
In contrast, concurrent in vivo administration of anti-IFN-Ǆ/mAb and OA or OA-POL 
results in marked increases in IL-4 and IL-10, and decreased IFN-Ǆ production, reflecting a 
polarization of the response towards a Th2-1ike pattern of cytokine synthesis. This is 
approach that allows selective activation of strongly Thl-dominated immune responses to 
protein antigens and it may be useful in clinical settings where the ability to actively select 
specific patterns of cytokine gene expression would be advantageous. Koppelman et al. 
(Koppelman et al., 2010) demonstrated that modification of peanut conglutin with 
glutaraldehyde (GA) does not result nor in a change of secondary structure nether in 
substantial decrease of IgE binding (only 2-3 fold). Reduction/alkylation treatment (RA) 
change secondary structures, whereas RA treatment followed by GA modification (RA-GA) 
results in a tertiary structure that differs from that of conglutin treated only with RA, due to 
modification of Cys and Lys residues. As demonstrated by IgE-ELISA and IgE blot 
treatment with RA-GA decreases IgE-binding up to a hundred fold and also induce a strong 
T cell response in T cell proliferation tests. These data demonstrate that all three 
modifications lead to a reduction in IgE binding, with the strongest reduction observed after 
both reduction/alkylation and glutaraldehyde treatment.  
3.1.1 Covalent hydrophilisation - conjugation with polysaccharides  
The shielding of epitopes by materials having low-antigenicity and immunogenicity may be 
efficient way of reducing allergenicity of the protein, especially with the use of a high 
molecular weight modifier to achieve effective shielding of epitopes. 
Carboxymethyldextran. Hattori et al. (Hattori et al., 2000) prepared BLG-carboxymethyl 
dextran conjugates (BLG-CMD), by using a water-soluble carbodiimide. The anti-BLG 
antibody response was markedly reduced after immunization with the BLG-CMD 
conjugates in mice. Linear epitope profiles of the BLG-CMD conjugates were similar to those 
of BLG, while the antibody response for each epitope was dramatically reduced. Reduction 
of immunogenicity of BLG depend on CMD content indicating that masking of epitopes by 
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CMD is responsible for the decreased immunogenicity of the BLG conjugates due to 
effective shielding by CMD. Similar result were obtained by Kobayashi et al. (Kobayashi et 
al., 2001) who prepared BLG-CMD with different molar ratios. Results of both studies show 
that conjugation with CMD of higher molecular weight is effective in reducing the 
immunogenicity of BLG by masking of B cell epitopes by CMD. In their further study 
Kobayashi et al. (Kobayashi et al., 2003), investigated changes in the T cell response to BLG 
after conjugation with CMDs. When lymph node cells from mice immunized with BLG or 
the conjugates were stimulated with BLG, T cells from the conjugate-immunized mice 
showed a lower proliferative response comparing to BLG-immunized mice (Fig.1). T cell 
epitope profiles of the conjugates were similar to those of BLG, whereas the proliferative 
response to each epitope was reduced, indicating that the lower in vivo T cell response with 
the conjugates was not due to induction of conjugate-specific T cells, but due to a decrease in 
the number of BLG-specific T cells. In addition, conjugation with CMD enhanced the 
resistance of BLG to cathepsin B and cathepsin D, suggesting that conjugation with CMD 
inhibited the degradation of BLG by proteases in antigen presenting cells (APC) and led to 
suppression of the generation of antigenic peptides including T cell epitopes from BLG. 
Therefore, the authors considered that the suppressive effect on the generation of T cell 
epitopes reduced the antigen presentation of the conjugates and this reduction led to a 
decrease in the number of BLG-specific T cells in vivo. As a result, the decreased help to B 
cells by T cells would have reduced the antibody response to BLG leading to conclusion that 
suppression of the generation of T cell epitopes by conjugation with CMD is important to 
the mechanism for the reduced immunogenicity of BLG. 
 
 
Fig. 1. Proliferative response to BLG of lymph node cells from mice immunized with BLG 
(circles) or the BLG-CMD conjugates (triangles) and stimulated with BLG at various 
concentrations. The magnitude of the in vivo T cell response was evaluated as the ex vivo 
proliferative response by BrdU ELISA. Each value is expressed as the mean absorbance at 
450 nm and standard deviation of triplicate cultures after subtracting the background values 
(stimulated with PBS). Significant differences (p < 0.05) between BLG and each conjugate 
were determined by Student’s t-test and are indicated by asterisks. Reprinted with 
permission from (Kobayashi et al., 2003). Copyright (2003) American Chemical Society. 
Acidic polysaccharides. Hattori et al. (Hattori et al., 2004) conjugated BLG with the acidic 
oligosaccharides, alginic acid oligosaccharide (ALGO) and phosphoryl oligosaccharides 
(Pos), by the Maillard reaction. Fluorescence studies indicated surface of each conjugate was 
covered with a saccharide chain. The anti-BLG antibody response was markedly reduced 
after immunization with both conjugates in mice. Linear epitope profiles of the conjugates 
were found to be similar to those of BLG, whereas the antibody response to each epitope 
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was dramatically reduced. In particular, effective reduction of the antibody response was 
observed in the vicinity of the carbohydrate-binding sites. Obtained conjugates are edible, 
have higher thermal stability and improved emulsifying properties than those of native 
BLG, thus being very useful for food application. Yoshida et al. (Yoshida et al., 2005) 
demonstrate that the T cell response was reduced when mice were immunized with BLG-
ALGO conjugates and that novel epitopes were not generated by conjugation. The authors 
clarified that the BLG-ALGO conjugate modulated the immune response to Th1 dominance 
and considered that this property of the BLG-ALGO conjugate would be effective for 
preventing food allergy as well as by its reduced immunogenicity. Therefore, conjugation 
with acidic oligosaccharides could be applied to various food allergens to achieve reduced 
allergenicity with multiple improvements in their properties. 
Galactomannan. Babiker et al. (Babiker et al., 1998) prepared soy protein-galactomannan 
conjugate by the Maillard reaction. Conjugation removed the allergenicity of the 34 kDa 
protein which is frequently recognized by the IgE antibody in the sera of soybean-sensitive 
patients as a major allergen. Monitoring of polyclonal antibody titers by an indirect enzyme-
linked immunosorbent assay and immunoblotting of rabbit sera, monoclonal antibody, and 
human allergic sera showed that soy protein-galactomannan conjugation was more effective 
in reducing the allergenicity of the soy protein than transglutaminase treatments and/or 
chymotrypsin. Additionally, heat stability, solubility and emulsifying properties were 
greatly improved by conjugation with galactomannan. 
Chitosan. Aoki et al. (Aoki et al., 2006) conjugated BLG with chitosan (CHS) by means of a 
water-soluble carbodiimide to reduce its immunogenicity. The antigenicity of the BLG-CHS 
conjugates was similar to that of BLG in C3H/He mice, while immunogemicity of BLG was 
reduced by conjugation. The linear epitope profiles of the conjugates were found to be 
similar to those of BLG, while the antibody response to each epitope was dramatically 
reduced. The researchers suggested masking of B cell epitopes as one of the mechanisms in 
reduction of immunogenicity. 
Dextran-glycylglycine and amylose-glycylglycine. Nodake et al. (Nodake et al., 2010) 
conjugated BLG with the N-hydroxysuccinimide ester of the dextran-glycylglycine adduct 
(DG-ONSu) to reduce the immunogenicity of BLG. Conjugation with DG-ONSu greatly 
decreased the reactivity of BLG with anti-BLG antibodies and suppressed their production 
in vivo due to its shielding action for epitope(s) on the protein's molecular surface. Beside, 
DG-BLG was resistant to proteolytic enzymes. In the other study (Nodake et al., 2011) these 
authors demonstrated that conjugation BLG with the N-hydroxysuccinimide ester of the 
amylose-glycylglycine adduct (AG-ONSu) also greatly decreased the reactivity of BLG. The 
authors proposed usage of DG-ONSu and AG-ONSu to suppress the hypersensitivity 
mediated by IgE antibodies in milk allergy. 
3.1.2 Covalent lipophilization  
Stearic acid. In the study of Akita and Nakai (Akita & Nakai, 1990) BLG was chemically 
modified by covalent attachment of different levels of stearic acid. A decreased in vitro 
digestibility was observed with extent of stearic acid incorporation (lipophilization). At low 
lipophilization increased ability to elicit IgE antibodies, determined by heterologous passive 
cutaneous anaphylaxis, was observed. Medium level of lipophilization decreased this 
ability, while high lipophilization almost destroyed the ability to elicit IgE antibodies. The 
researchers also found that low- and medium-lipophilization increased while high 
lipophilization decreased the IgG binding ability, measured by ELISA. 
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3.2 Noncovalent modifications 
Components of food matrix can interact noncovalentlly with food allergens resulting 
insoluble complexes thus lowering the level of soluble allergens and reducing their 
allergenic properties. Also they can reduce digestibility of food allergens and consequently 
their allergenicity by hindering access of digestive enzymes. Phenolic compounds and 
phytic acid are known to form soluble and insoluble complexes with proteins. For instance, 
it was shown that multivalent hydrophobic interactions cause compaction of cow’s milk 
caseins with the polyphenol epigallocatechin in way that individual casein molecules “wrap 
around” polyphenol (Jobstl et al., 2006). 
Phytic acid. Chung et al. (Chung & Champagne, 2007) treated peanut extract with phytic acid 
and demonstrated that phytic acid formed complexes with the major peanut allergens (Ara h 1 
and Ara h 2), reducing their solubility in acidic and neutral conditions. Also, 6-fold reduction 
in IgE binding of the extract was observed after treatment with phytic acid, observed by 
competitive inhibition ELISA using a pooled serum from peanut-allergic individuals. Similar 
result obtained with peanut butter slurry led to the suggestion that phytic acid treatment 
might reduce the allergenicity of peanut-based products due to reducing their solubility (Fig 
2). In another study by the same group of authors, a facilitated IgE binding in vitro was 
observed was peanut allergens and phytic acid. Apparently, phytic acid was able to stabilize 
allergen-antibody interactions (Chung & Champagne, 2006) However, usage of phytic acid 
might be limited considering its anti-nutritive properties due to ability to chelate iron.  
 
 
Fig. 2. a) SDS-PAGE and b) competitive inhibition ELISA of natural peanut butter slurry 
treated and centrifugated with and without phytic acid. Values are means ± SD (n=3). 
Values of the treated samples at 0.01–100 µg/mL are significantly different from those of the 
control (P < 0.05, n=3). Reprinted with permission from (Chung & Champagne, 2007). 
Copyright (2003) American Chemical Society. 
Phenolic compounds: Adding of phenolics such as caffeic, chlorogenic and ferulic acids to 
peanut extracts, liquid peanut butter and peanut butter slurries, precipitated most of the 
major peanut allergens, Ara h 1 and Ara h 2, and complexation was irreversible (Chung & 
Champagne, 2008; Chung & Champagne, 2009). Of the three phenolics, caffeic acid formed 
the most precipitates with peanut extracts. IgE binding was reduced approximately 10- to 
16-fold as determined by inhibition ELISA (Fig. 3). Assuming that the insoluble complexes 
are not absorbed by the body the researchers concluded that reducing IgE binding by 
www.intechopen.com
 
Enzymatic and Chemical Modifications of Food Allergens 
 
91 
phenolics is feasible and have a great potential in development of less allergenic liquid 
peanut-based products.  
 
 
Fig. 3. IgE binding of phenolic-treated and untreated peanut extracts in competitive 
inhibition ELISA using pooled human plasma from peanut-allergic individuals. Values (on 
semi-log scale) are mean of three determinations. Values between treatments (caffeic, 
chlorogenic, and ferulic) are not significantly different from each other but from the 
untreated (P < 0.05). Reprinted from (Chung & Champagne, 2009 ), Copyright (2009), with 
permission from Elsevier. 
Polysaccharides. Mouecoucou et al. (Mouecoucou et al., 2004) examined the influence of 
polysaccharides, i.e., gum arabic, low methylated pectin (LMP) and xylan, on the in vitro 
hydrolysis of peanut protein isolate (PPI) and the in vitro allergenicity of the digestion 
products. PPI was hydrolyzed in vitro by pepsin, followed by a trypsin/ chymotrypsin 
(T/C) mixture in dialysis bags. Hydrolysis by all of the digestive enzymes showed retention 
of some proteins in the dialysis bags in the presence of gum arabic and xylan. The retentates 
were recognized by IgG and IgE, but IgE binding of retentate containing xylan was reduced. 
The immunoreactivity of hydrolysis products in dialysates was considerably reduced by 
polysaccharides. Polovic et al. (Polovic et al., 2007) demonstrated that addition of apple fruit 
pectin (1.5% and 3%) to the purified kiwi allergen Act c 2 was able to protect it from pepsin 
digestion in vitro. In vivo experiments on healthy non-atopic volunteers have shown that 1 h 
after ingestion of kiwi fruit in gastric content intact Act c 2 was still present. In their further 
work Polovic et al. (Polovic et al., 2010) discovered that after in vivo digestion of Act c 2 with 
pure pectin in rats both gastric acidity, as well as specific and total pepsin activity declined 
and thus protected 23% of the ingested allergen from digestion for 90 minutes. These results 
show that although presence of polysaccharides can be effective in masking of IgE epitopes, 
thus reducing allergenicity, it also reduces allergen digestibility, enabling higher dosages of 
the allergen to reach the immune system. 
Oxidized lipids. In study of Doke et al. (Doke et al., 1989) though oxidized soybean oil did 
not show any allergenicity, the IgE titer of sera from soybean-sensitive patients (in ELISA) 
was greatly increased when oxidized soybean oil was incubated with soybean 2S-globulin. 
The IgE titer became higher when greater amounts of oxidized soybean oil were used, but 
little difference was noted when soybean 2S-globulin was replaced by other food proteins. A 
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similar tendency was noted when soybean oil was replaced by other vegetable oils or fatty 
acids. The authors speculated that proteins interacted with oxidized lipid are allergenic to 
soybean-sensitive patients probably due to creation of new epitopes.  
3.3 Modifications by oxidation/reduction 
Oxidation. Heavy metal ions (Cu2+, Fe 2+, etc.) with hydrogen peroxide can cross-link 
proteins through oxidation of their tyrosine residues and forming dityrosine and 
isodityrosine, as well as by oxidation of sulfhydriles resulting in disulfides. In study of 
Chung et al. (Chung, 2005) extracts from raw and roasted peanuts were treated with 
Cu2+/H2O2 and only roasted peanuts were affected by Cu2+/H2O2 . In this case cross-links 
were formed and levels of Ara h 1 and Ara h 2 were reduced as shown in competitive 
inhibition ELISA with pooled serum of peanut-allergic individuals. IgE binding, overall, 
was lower despite some binding of IgE to cross-links leading to conclusion that Cu2+/H2O2 
reduced peanut allergenicity by inducing the decrease and cross-linking of peanut allergens.  
Reduction. The proteins are allergenically active and less digestible in the oxidized (S--S) 
state. When reduced (SH state), they lose their allergenicity and/or become more digestible. 
Allergen reduction can be performed by using a reducing agent such as 2-mercaptoethanol, 
dithiothreitol, cysteine, glutathione, etc., or by using proteins glutaredoxin or thioredoxin. In 
study of Buchanan et al. (Buchanan et al., 1997) thioredoxin mitigated the allergenicity of 
whey flour proteins, gliadins and glutenins, as determined by skin tests with a canine model 
for food allergy, but gave less consistent results with albumins and globulins. In the study of 
de Val et al. (del Val et al., 1999) after reduction of one or both of its disulfide bonds by 
thioredoxin, BLG became strikingly sensitive to pepsin in simulated gastric fluid and lost its 
allergenicity as determined by skin test responses and gastrointestinal symptoms in inbred 
colony of high IgE–producing dogs sensitized to milk. Koppelman et al. (Koppelnan et al., 
2007) modified 2S albumins by reduction by thioredoxin, resulting in breakage of disulfide 
bonds, followed by alkylation for prevention of reformation of disulfide bonds. Oral 
administration of native 2S albumin resulted in the development of Th-1 mediated IgG1- 
and Th-2 mediated IgG2a and IgE responses in the rat, as determined by ELISA. Oral 
exposure to RA-2S albumin did not result in the development of specific IgE against RA-2S, 
but IgGl and IgG2a antibodies against RA-2S albumin were formed in a lower level 
compared to native 2S albumin. Dosing of the animals with the low dose RA-2S albumin 
(0.1 mg protein/rat/day) did not result in an antibody response at all in the rats whereas the 
same dose of native 2S albumin induced specific IgGI, IgG2a and IgE responses, again 
indicating a lesser immunogenicity. Taken together, these data show that reduction of the 
disulphide bonds of 2S albumin results in loss of allergenicity and an increased sensitivity to 
digestion. All these results provide evidence that thioredoxin can be applied to enhance 
digestibility and lower allergenicity of food proteins. However, thioredoxins represent a 
novel family of cross-reactive allergens involved in the pathogenesis of atopic eczema and 
asthma. Also, cross-reactivity to human thioredoxin can contribute to the exacerbation of 
severe atopic diseases by involvement of IgE-mediated autoreactivity (Glaser et al., 2008). 
Considering these facts usage of thioredoxin in food allergen modification might be limited.  
4. Enzymatic modifications 
Beside proteolytic enzymes, enzymes able to cross-link proteins have shown to be promising 
tools for reduction of allergenicity of food proteins. Enzymatic cross-linking of proteins, by 
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transglutaminases, peroxisases and phenol oxidases (such as tyrosinases and laccases), is 
currently exploited in the food processing industry (Buchert et al., 2007). 
4.1 Transglutaminases  
Transglutaminases (TG) catalyze formation of a covalent bond between a primary amines 
(including ε-amino group of lysine residues) and the Ǆ-carboxamid group of protein-bound 
glutamine leading to protein cross-linking.  
Villas-Boas et al. (Villas-Boas et al., 2010) polymerized heat treated BLG and TG (BLG-TG) 
and untreated BLG in the presence of cysteine and TG (BLG-Cys-TG). BALB/c mice 
sensitized with BLG-Cys-TG showed lower levels of IgG1 and IgE than those immunized 
with native BLG or BLG-TG, suggesting that polymerization in the presence of Cys 
modified or hid epitopes, reducing the potential antigenicity of BLG. Clare et al. (Clare et al., 
2007) cross-linked peanut flour dispersions with transglutaminase in the presence and 
absence of the dithiothreitol. Transglutaminase treatment did not diminish IgE binding 
responses in ELISA implying only that transglutaminase cross-linking do not enhance 
potential for allergic responses. In their further study Clare et al. (Clare et al., 2008) cross-
linked light roasted peanut flour (PF) with transglutaminase with casein (CN) as co-
substrate. In immunoblotting, in some patient sera IgE binding to TGase-treated PF-CN 
fractions appeared less compared to equivalent polymeric PF dispersions lacking 
supplemental CN and non-cross-linked PF-CN samples. The researchers assumed that 
covalent modification masked IgE peanut protein binding epitopes, at least to some degree, 
on an individual patient basis.  
In study of Wroblewska et al. (Wroblewska et al., 2008) whey protein concentrate (WPC) 
was modified by two enzymes: proteinase Alcalase and transglutaminase. The new 
products were characterized by 2D electrophoresis, immunoblotting, and ELISA methods. 
The WPC hydrolysate obtained with Alcalase contained proteins and peptides showing 
strong immunoreactive properties, as revealed by immunoblotting with ǂ-la and ǃ-lg 
polyclonal rabbit antibodies. However, the immunoblot analysis demonstrated that WPC 
showed a stronger reactivity towards IgE of allergic patients then WPC treated with 
transglutaminase. ELISA assay with human sera showed that two-step modification with 
Alcalase followed by TG significantly reduced the immunoreactive properties of whey 
proteins. Patients with wheat-dependent, exercise-induced anaphylaxis (WDEIA) 
experience recurrent anaphylactic reactions when exercising after ingestion of wheat 
products.  
Palosuo et al. (Palosuo et al., 2003) digested purified ω-5 gliadin, major allergen in WDEIA, 
with pepsin or with pepsin/trypsin and treated with tissue transglutaminase (tTG). The IgE-
binding ability of ω-5 gliadin was retained after pepsin and pepsin-trypsin digestion, as 
shown in IgE ELISA test. tTG treatment of the whole peptic digest resulted in cross-linked 
aggregates which bound IgE antibodies in immunoblotting more intensely than untreated, 
pepsin-digested, or pepsin-trypsin–digested ω-5 gliadin. In the 20 WDEIA patients the mean 
skin prick test wheal elicited by tTG treated peptic fraction was 77% larger than that elicited 
by the untreated peptic fraction and 56% larger than that elicited by intact ω-5 gliadin. These 
results suggest that activation of tTG during exercise in the intestinal mucosa of patients 
with WDEIA could lead to the formation of large allergen complexes capable of eliciting 
anaphylactic reactions. Leszczynska et al. (Leszczynska et al., 2006) modified wheat flour by 
the treatment with transglutaminase and demonstrated, in indirect non-competitive ELISA 
with human sera, reduction of glutenin immunoreactivity to below 30%.  
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Watanabe et al. (Watanabe, 2004) have made hypoallergenic flour by flour treatment with 
actinase, collagenase, and transglutaminase and that TG is the least effective of tested 
enzymes in reducing flour allergenicity. Soy protein-galactomannan conjugation was more 
effective in reducing the allergenicity of the soy protein than transglutaminase treatments 
(Babiker et al., 1998) (Fig. 4). In the study of Monogioudi et al. (Monogioudi et al., 2011) ǃ-
casein was cross-linked of by transglutaminase and demonstrated that enzymatically cross-
linked ǃ-casein was stable under acidic conditions and was more resistant to pepsin 
digestion when compared to non cross-linked ǃ-casein. In the study of Stanic et al (Stanic et 
al., 2010) TG-treated casein showed no mitigated IgE binding reactivity compared with the 
untreated CN in BAT.  
 
 
Fig. 4. Determination of antibody titers by indirect ELISA of acid precipitated soy protein 
(APP), chymotrypsin digest (APPC), transglutaminase treated APP and galactomannan 
conjugate dry heated for 7 days. Error bars indicate the standard deviations (n=6). Reprinted 
with permission from (Babiker et al., 1998). Copyright (1998) American Chemical Society. 
As a microbial TG is included in many food technological processes, safety of the TG itself, 
as well as safety of the deamidated/cross-linked proteins generated by this enzyme should 
be checked (Malandain, 2005). In their study, Pedersen et al. (Pedersen et al., 2004) 
investigated the allergenicity of TG from Streptoverticillium mobaraens by evaluation of amino 
acid sequence similarity to known allergens, pepsin resistance, and detection of protein 
binding to specific serum immunoglobulin E (IgE) (RAST) evaluated as recommended by 
2001 FAO/WHO Decision Tree, recommended for evaluation of proteins from genetically 
modified organisms (GMOs). All tests demonstrated that there is no safety concerns with 
regard to the allergenic potential of tested TG. 
4.2 Peroxidases 
Peroxidases (POD) are a heme-containing enzymes catalyzing the oxidation of a variety of 
organic compounds by hydrogen peroxide or hydroperoxides. Acting on phenolic 
compounds POD generate o-quinones, which further react with other phenolics, amino, or 
sulfhydryl compounds in proteins to form cross-linked products. 
In their study Chung et al. (Chung et al., 2004) have treated protein extracts from raw and 
roasted defatted peanut meals with POD in the presence of hydrogen. While POD treatment 
had no effect on raw peanuts, a significant cross-linking and decrease in the levels of the 
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major allergens, Ara h 1 and Ara h 2, in roasted peanuts (Fig.7) was observed in imunoblots 
and IgE ELISA. The authors suppose that POD induced the cross-linking of mainly Ara h 1 
and Ara h 2 from roasted peanuts and that, due to POD treatment, IgE binding was 
reduced.  
Garcia et al. (Garcia et al., 2007) investigated effect of peroxidase and antioxidant 
diethyldithiocarbamic acid (DIECA) on IgE-binding by Mal d 1, the major apple allergen. In 
competitive ELISA IgE-binding by Mal d 1 decreased by adding peroxidase with more 
pronounced effect in presence of catechin. DIECA protected the IgE-binding by the allergen, 
protection being less strong in the presence of exogenous peroxidase (Fig 5).  
Weangsripanaval et al. (Weangsripanaval et al., 2003) purified and characterized new 
allergenic protein from the tomato identified as suberization-associated anionic peroxidase 
1. Furthermore, SanchezMonge et al. (SanchezMonge et al., 1997) purified and characterized 
allergenic protein from wheat flour identified as seed-specific peroxidase. These facts imply 
that peroxidases themselves can be allergens and safety for use them must be assessed. 
 
 
Fig. 5. Influence of the treatments performed on apple peel samples on Mal d 1 
concentration determined by competitive ELISA using a pool of sera. The treatments 
consisted of: additional peroxidase (POD), additional substarte catechin, additional catechin 
combined with POD, additional diethyldithiocarbamic acid (DIECA) and additional DIECA 
combined with POD.T he incubation times were 0, 1, 2, 5, and 24 h at room temperature. 
Reprinted from (Garcia et al., 2007), Copyright (2007), with permission from Elsevier.  
4.3 Phenol oxidases 
4.3.1 Polyphenoloxidases (tyrosinases)  
Polyphenol oxidases (PPO) or tyrosinases are bifunctional enzymes catalyzing o-
hydroxylation of monophenols (including protein-bound tyrosine residues) to o-diphenols 
and subsequent oxidation of o-diphenols to o-quinones (Lerch, 1983). Reactive o-quinones 
can further undergo non-enzymatic polymerization or can react with amino acid residues in 
proteins. 
In the study of Gruber et al. (Gruber et al., 2004) incubation of recombinant Pru av 1, major 
cherry allergen, with phenol compounds in the presence of tyrosinase led to decrease in IgE-
binding activity of the protein as revealed by EAST and inhibition assays. Caffeic acid and 
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epicatechin showed to be the most efficient in decreasing of rPru av 1 IgE-binding activity, 
followed by catechin and gallic acid, while quercetin and rutin were the least efficient. 
However, PPO without the addition of a phenolic compound did not display a reduction in 
IgE binding. The researchers speculated that, reactive intermediates formed during 
enzymatic polyphenol oxidation are responsible for modifying nucleophilic amino acid side 
chains of proteins, thus inducing an irreversible change in the tertiary structure of the 
protein and resulting in a loss of conformational epitopes of the allergen. In study of Chung 
et al. (Chung et al., 2005) peanut extracts were treated with and without PPO, PPO/caffeic 
and caffeic acid. All treatments resulted in cross-linking and decreased the levels and IgE 
binding (competitive inhibition ELISA) of two peanut major allergens, Ara h 1 and Ara h 2, 
with PPO/caffeic as the most effective (Fig.6).  
 
 
Fig. 6. Inhibition of IgE antibodies in a competitive inhibition ELISA by (a) PPO- and 
PPO/caffeic-treated extracts, pH 8, and (b) caffeic-treated extract, pH 10.5. Extracts, diluted 
at the concentration indicated, were each mixed with a pooled serum from peanut allergic 
individuals, and then added to an allergen-coated microtiter plate. Values are means ± SD (n 
= 3). Values of the treated samples at 1–100 μg mL−1 are significantly different from those of 
the control (P < 0.05, n = 3).Reprinted from (Chung et al., 2005), Copyright (2005), with 
permission from John Wiley and Sons.  
In their further study Chung et al. (Chung & Champagne, 2008) treated peanut butter 
slurries with phenolic compounds/PPO and obtained reduction in IgE-binding, despite the 
formation of soluble allergen complexes or cross-links, for which authors assume that are 
less allergenic. Novotna et al. (Novotna et al., 2011) investigated effects of celery juice by 
oxidation by utilising its natural polyphenol oxidase (PPO) content on the reduction of the 
content of the Api g1, the main celery allergen. Oxidation failed to eliminate the 
allergenicity of pure celery juice, but oxidation in apple-celery juices reduced the 
allergenicity of the mixture. However, the basophil activation test showed no reduction in 
the allergic response to the oxidised juice mixture. Skin testing showed that the prolonged 
oxidation of juice mixture showed significantly lower reaction, while apple juice stabilised 
with ascorbic acid did not have effect. Due to the contradictory results in different tests, the 
method cannot be declared successful or safe, even for mixtures of apple-celery juices. In 
competitive ELISA Garcia et al. (Garcia et al., 2007) demonstrated decreased IgE binding of 
Mal d 1 after enrichment of apple extract with PPO, with the strongest effect in presence of 
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catechin. Antioxidant DIECA protected the IgE-binding by the allergen, protection being less 
strong in the presence of exogenous PPO. Schmitz et al. (Schmitz-Eiberger & Matthes, 2011) 
evaluated relationship between Mal d 1, the main apple allergen, content and PPO, total 
phenol content and antioxidative capacity in different apple varietie. Whereas higher PPO 
activities and polyphenols contents result in less extractable Mal d 1, higher antioxidative 
activity can inhibit the interaction between oxidised phenols and Mal d 1, resulting in higher 
allergenicity (extractable Mal d 1). In the study of Monogioudi et al. (Monogioudi et al., 2011) 
ǃ-casein was cross-linked of by tyrosinase and demonstrated that enzymatically cross-linked 
b-casein was stable under acidic conditions and was more resistant to pepsin digestion when 
compared to non cross-linked b-casein. In the study of Stanic et al. (Stanic et al., 2010) 
tyrosinase treated casein showed mitigated IgE binding reactivity, compared with the 
untreated CN, only in the presence of caffeic acid as mediator in BAT.  
4.3.2 Laccases 
Laccases catalyse oxidation of various phenolic compounds with one electron mechanism 
generating free radical species. Reactive free radicals can further undergo non-enzymatic 
polymerization or can react with high redox potential substrate targets, such as amino acid 
residues in proteins (Canfora et al., 2008). 
 
 
Fig. 7. Basophil activation to casein and crosslinked caseins in seven patients with CMA. 
p<0.05 was statistically significant difference in a Wilcoxon-maitched pairs test. Reprinted 
from (Stanic et al., 2009), Copyright (2009), with permission from John Wiley and Sons.  
Tantoush et al. (Tantoush et al., 2011) cross-linked BLG by laccase in the presence of an sour 
cherry phenolics. In a BAT assay, the allergenicity of the cross-linked protein was shown to 
decrease in all nine cow’s milk-allergic patients, while digestibility of the remaining 
monomeric BLG in simulated conditions of the gastrointestinal tract increased. In the further 
study of Tantoush et al. (Tantoush et al., 2011) cross-linking BLG by laccase in the presence 
of apple phenolics (APE) rendered the protein insoluble in the reaction mixture consisting of 
cross-linked BLG, with a fraction of the BLG remaining monomeric. Enzymatic processing 
of BLG decrease the bi-phasal pepsin–pancreatin digestibility of the monomeric and cross-
linked protein, thus decreasing its nutritional value. Stanic et al. (Stanic et al., 2010) 
crosslinked ǃ-casein (CN) by laccase and caffeic acid and demonstrated that crosslinking 
was not very efficient, leaving mostly monomeric CN modified by caffeic acid. Regardless to 
that ability of crosslinked CNs to activate basophils was significantly reduced in seven 
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patients and reduced inhibition potential is possibly due to hindering of epitopes by 
monomer modification. Also, digestion of crosslinked CN by pepsin was hampered.  
As enzyme preparations used in food technology are food grade, but often not of the highest 
purity, they can contain contaminating enzyme activities. These so-called ‘‘side activities’’ 
even if present only in trace quantities, can have unpredictable influence on functional 
properties, nutritional quality and safety of food implying that effects of contaminating 
enzymes in used enzyme preparations should be carefully monitored. Stanic et al. (Stanic et 
al., 2009) found out that in the presence of high purity commercial laccase and tyrosinase 
preparations, both variants of BLG (A and B) underwent removal of a peptide from the N-
terminus. The truncated forms were more susceptible to digestion by pepsin and thus with 
lower allergenic potential. 
5. Conclusion 
In development of new methods for food allergen modification there are two main 
applications. First one, and the most frequent, is creation of hypoallergic food and food 
additives, and the second one is preparation of formulations for safe immunotherapy of 
food allergies. In addition to the main aim, reduction of allergenicity, there are several other 
requirements that must be satisfied for certain application. For both applications safety is 
obligatory, implicating usage of minimal toxic and nonalleregnic agents, including the main 
and auxiliary one. Preferred reagents used for allergen modification are those acceptable for 
the production of foodstuffs or pharmaceuticals. In that sense, recent researches are more 
focused on usage of enzymes as modification agents, as well as compounds naturally 
occurring in food. Also, all products of modification reaction, not only modified allergen, 
must be safe or successfully eliminated/degraded in further processing and expenses of 
method have to be reasonable. For food industry desirable physico-chemical properties of 
modified proteins are important as they determine technological properties such as 
solubility, pH stability, gelling, foaming, emulsifying properties etc., as well as nutritional 
value and impact on taste and flavor. Allergen modifications, although efficient in reducing 
allergenicity, do not bare potential for application in food industry if mentioned properties 
are significantly disturbed, as for food industry the most important is consumer`s 
acceptance of certain food (texture, taste, stability, natural origin, etc.). Typical example are 
extensive protein hydrolysates, although highly hypoallergenic, having bitter taste, which is 
difficult to mask, and high osmolarity. For immunotherapy preparations, in addition to 
reduced/eliminated allergenicity and preserved immunogenicity, immunomodulatory 
properties are highly desirable for increasing immunotherapy efficiency. Also, physico-
chemical properties of modified proteins define their stability, such as susceptibility for 
proteolysis and heat denaturation. 
There is numerous studies focusing on modification of food protein as new properties 
enable design of more different food products and exploitation of cheap high nutritional 
food sources. Many of methods for reducing food protein allergenicity emerged from these 
studies, as evidenced by in parallel investigation of techno-functional properties and 
allergenicity testing in some publications. Reducing of allergenic properties by chemical or 
enzymatic methods was demonstrated on full extract, raw or pretreated, or on isolated 
allergens from peanut, wheat, whey, soy, pea and cherry. The most frequently modified 
food allergens are BLG and ovalbumin. BLG was interesting due to its high nutritional 
value, important functional properties and its availability as by-product cheese industry. 
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Ovalbumin was the most frequently used as a model allergen in studies using animal 
models. 
As reducing of alleregenicity can be achieved by removal of epitopes, destruction of 
epitopes, and by their masking, knowledge of the structural aspects of allergenicity and of 
the factors that determine epitope integrity will lead to novel and more specific approaches 
to decrease allergenicity. By treatment with chemical or enzyme agent only few amino acid 
residues of allergen react, such as residues of lysine, arginine, cystein, tyrosine. Therefore, 
epitope containing these residues are expected to be changed/masked in significant extent 
and knowing the epitope structure can help in prediction which method would be the most 
successful. In addition to B cell epitope changes, changes in T cell eptopes can significantly 
contribute reduction of allergic response as well. T cells provide help to B cells, by direct 
interaction and secretion of cytokines, and promote their proliferation and differentiation 
into antibody producing cells (Kaminogava, 1996). Therefore, during allergen modification 
formation of bonds non-hydrolisabile by processing machinery in APC, can change T cell 
epitope profiles of allergens and have influence on direction of immune response, 
potentiating allergy or tolerance. 
It seems that the most effective approach for allergen modification is combination of two or 
more methods acting by different mechanisms, such as combination of acylation and 
proteolysis (Szymkiewicz & Jedrychowski, 2008), reduction, alkylation and cross-linking 
(Koppelman et al., 2010), cross-linking and reduction (Villas-Boas et al., 2010), proteolysis 
and cross-linking (Wroblewska et al., 2008). Covalent modification of allergens by edible 
high molecular mass polysaccharides is effective and acceptable way for designing 
hypoallergic food formulatios offering also improved techno-functional properties. 
However, low immugenicity of modifications limits this method for creation of effective 
immunotherapy preparations.  
Of all applied cross-linking enzymes it seems that transglutaminase is the least efficient in 
reducing protein allergenicity, and only when it is combined with allergen reduction or in 
the presence of co-substrate or with proteolysis. Although for the efficiency of peroxidase 
there are only sparse data, food allergen cross-linking with phenol oxidases (tyrosinases, 
laccases) with assistance of small phenolic compounds have great potential. It looks like that 
protein cross-linking itself is not enough for significant masking IgE epitopes and that 
phenolic mediators contribute by modification of the nucleophilic surface residues in the 
protein and the hindering of the epitopes by their covalent attachment in a highly 
aggregated product, as well as to monomer allergen. Also, it seems that cross-linked 
allergens are more resistant to digestion then their monomeric form. It is well known that 
proteins resistant to both gastric and intestinal digestion are not allergenic. The data from 
animal models show that both gastric and intestinal-resistant allergens do not carry strong 
food-allergy risk or induce oral tolerance, simply because both food-allergy and oral-
tolerance are MHC class II-dependent processes and require antigen presentation to the 
immune system i.e. readily available peptides in intestinal fluids (Bowman & Selgrade, 
2008).  
For the most methods mentioned in this review exhaustive studies on human subjects, 
including DBPCFC tests, are needed in order to design food with label hypoallergenic. As 
substantial part of the population reacts to very low amounts of allergens, residual 
unmodified allergen that remain after modification can still bind IgE and elicit symptoms in 
highly sensitive patients (Wensing et al., 2002). Also some modifications may be clinically 
relevant for some allergic individuals but not for others. The method for allergen 
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modification applied to food source, such as wheat, peanut, soy flour or WPI, may change 
different allergens to a different extent. Therefore, methods enabling a reduction of 
allergenicity of all proteins should be used or different types of modification should be 
applied simultaneously.  
In the future further and more fundamental researches in this multidisciplinary field is 
necessary in order to develop novel hypoallergenic foods and food additives on one hand, 
and to obtain suitable preparations enabling safe and efficient food allergen-specific 
immunotherapy in clinical practice on the other hand.  
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